Publicaciones en colaboración con investigadores/as de Centro Nacional de Biotecnología (39)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

    Vaccines, Vol. 12, Núm. 1

  3. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium (npj Vaccines, (2024), 9, 1, (53), 10.1038/s41541-024-00838-8)

    npj Vaccines

  4. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  5. Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium

    Emerging Microbes and Infections, Vol. 13, Núm. 1

  6. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium

    npj Vaccines, Vol. 9, Núm. 1

  7. SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells

    Cellular and Molecular Biology Letters, Vol. 29, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. In silico evaluation and selection of the best 16S rRNA gene primers for use in next-generation sequencing to detect oral bacteria and archaea

    Microbiome, Vol. 11, Núm. 1

  3. Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection

    Antiviral research, Vol. 220, pp. 105760

  4. MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated

    Frontiers in Cell and Developmental Biology, Vol. 10

  5. Viral protein nanoparticles (Part 1): Pharmaceutical characteristics

    European Journal of Pharmaceutical Sciences, Vol. 187

2022

  1. ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing

    Clinical Chemistry, Vol. 68, Núm. 5, pp. 668-679

  2. Overview of the regulation of the class IA PI3K/AKT pathway by SUMO

    Seminars in Cell and Developmental Biology, Vol. 132, pp. 51-61

  3. eIF5A is activated by virus infection or dsRNA and facilitates virus replication through modulation of interferon production

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2021

  1. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

    Nature Communications, Vol. 12, Núm. 1

  2. Expression of the ebola virus vp24 protein compromises the integrity of the nuclear envelope and induces a laminopathy-like cellular phenotype

    mBio, Vol. 12, Núm. 4

  3. Is Carotid Body Infection Responsible for Silent Hypoxemia in COVID-19 Patients?

    Function, Vol. 2, Núm. 1

  4. SUMOylation modulates the stability and function of PI3K-p110β

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 8, pp. 4053-4065

2020

  1. SUMO and cytoplasmic RNA viruses: From enemies to best friends

    Advances in Experimental Medicine and Biology (Springer), pp. 263-277